SYROS

Serial Number 85804144
Registration 4499234
800

Registration Progress

Application Filed
Dec 17, 2012
Under Examination
Jul 9, 2013
Approved for Publication
Apr 24, 2013
Published for Opposition
May 14, 2013
Registered
Mar 18, 2014

Trademark Image

SYROS

Basic Information

Serial Number
85804144
Registration Number
4499234
Filing Date
December 17, 2012
Registration Date
March 18, 2014
Published for Opposition
May 14, 2013
Renewal Date
March 18, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Jun 17, 2024
Registration
Registered
Classes
042

Rights Holder

Syros Pharmaceuticals, Inc.

03
Address
35 CambridgePark Dr, 4th Floor
Cambridge, MA 02140

Ownership History

Syros Pharmaceuticals, Inc.

Original Applicant
03
Watertown, MA

Syros Pharmaceuticals, Inc.

Owner at Publication
03
Watertown, MA

Syros Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Nathan T. Harris

USPTO Deadlines

Next Deadline
3151 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2014-03-18)
Due Date
March 18, 2034
Grace Period Ends
September 18, 2034

Application History

39 events
Date Code Type Description Documents
Jun 17, 2024 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jun 17, 2024 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Jun 17, 2024 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jun 17, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Mar 15, 2024 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Mar 18, 2023 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Nov 19, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 19, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 19, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 19, 2020 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Apr 19, 2020 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Apr 19, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Feb 24, 2020 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Feb 24, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 24, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 24, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 24, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 24, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 18, 2014 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 12, 2014 SUNA O NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED Loading...
Feb 11, 2014 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED Loading...
Feb 11, 2014 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 11, 2014 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Feb 10, 2014 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 10, 2014 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 9, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 9, 2014 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 9, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 19, 2013 IUAF S USE AMENDMENT FILED Loading...
Dec 19, 2013 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 9, 2013 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 14, 2013 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 24, 2013 NPUB O NOTICE OF PUBLICATION Loading...
Apr 11, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 2, 2013 ALIE A ASSIGNED TO LIE Loading...
Apr 1, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 1, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 4, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 20, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
consulting services in the field of pharmaceutical research and development; research and development of pharmaceuticals and compounds for the treatment of cancer; research and development of pharmaceuticals and compounds for inhibition of transcriptional regulators; research and development of pharmaceutical preparations and medicines for others
First Use Anywhere: Apr 11, 2013
First Use in Commerce: Apr 11, 2013

Classification

International Classes
042